Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 5,220,846 | 9,066,621 | +3,845,775 | $229.98M | $445.72M | 29.51% | +$215.74M |
| Krystal Biotech, Inc.(KRYS) | 677,705 | 673,505 | -4,200 | $167.08M | $173.98M | 11.52% | +$6.90M |
| Stoke Therapeutics, Inc.(STOK) | 4,034,070 | 4,164,120 | +130,050 | $128.04M | $135.58M | 8.98% | +$7.54M |
| Immunome, Inc.(IMNM) | 5,718,385 | 5,558,885 | -159,500 | $122.83M | $121.57M | 8.05% | -$1.26M |
| Nurix Therapeutics, Inc.(NRIX) | 8,093,908 | 7,732,808 | -361,100 | $153.54M | $119.86M | 7.94% | -$33.68M |
| Annexon, Inc.(ANNX) | 10,050,644 | 14,549,768 | +4,499,124 | $50.45M | $80.61M | 5.34% | +$30.15M |
| ADC Therapeutics SASHS(ADCT) | 15,666,731 | 15,470,502 | -196,229 | $55.30M | $58.01M | 3.84% | +$2.71M |
| REGENXBIO Inc.(RGNX) | 4,368,804 | 4,368,804 | 0 | $62.91M | $36.61M | 2.42% | -$26.30M |
| Shattuck Labs, Inc.(STTK) | 5,539,724 | 5,539,724 | 0 | $20.22M | $35.62M | 2.36% | +$15.40M |
| Beam Therapeutics Inc.(BEAM) | 1,285,859 | 1,237,659 | -48,200 | $35.64M | $29.49M | 1.95% | -$6.15M |
| Neurogene Inc.(NGNE) | 1,459,599 | 1,459,599 | 0 | $30.07M | $29.43M | 1.95% | -$642.2K |
| Cogent Biosciences, Inc.(COGT) | 1,437,918 | 688,036 | -749,882 | $51.07M | $26.48M | 1.75% | -$24.59M |
| Absci Corporation | 8,253,316 | 8,253,316 | 0 | $28.80M | $24.76M | 1.64% | -$4.04M |
| IDEAYA Biosciences, Inc.(IDYA) | 742,017 | 521,117 | -220,900 | $25.65M | $17.36M | 1.15% | -$8.29M |
| ALX Oncology Holdings Inc.(ALXO) | 3,264,718 | 7,964,188 | +4,699,470 | $3.69M | $15.97M | 1.06% | +$12.28M |
| Fate Therapeutics, Inc.(FATE) | 12,872,946 | 12,872,946 | 0 | $12.65M | $15.45M | 1.02% | +$2.80M |
| Xenon Pharmaceuticals Inc.(XENE) | 133,882 | 262,674 | +128,792 | $6.00M | $15.27M | 1.01% | +$9.27M |
| Solid Biosciences Inc | 1,860,542 | 2,011,895 | +151,353 | $10.49M | $14.49M | 0.96% | +$3.99M |
| Nuvation Bio Inc.CL A(NUVB) | 3,163,256 | 3,153,256 | -10,000 | $28.34M | $13.53M | 0.90% | -$14.82M |
| Zymeworks Inc.(ZYME) | 491,654 | 491,654 | 0 | $12.95M | $12.31M | 0.82% | -$634.2K |
| Silence Therapeutics plcADS(SLN) | 2,164,777 | 2,164,777 | 0 | $13.16M | $11.41M | 0.76% | -$1.75M |
| DBV Technologies S.A.ADS(DBVT) | 549,840 | 491,340 | -58,500 | $10.54M | $10.26M | 0.68% | -$276.3K |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 173,859 | +173,859 | $0 | $9.82M | 0.65% | +$9.82M |
| Celldex Therapeutics, Inc.(CLDX) | 283,308 | 261,508 | -21,800 | $7.69M | $8.30M | 0.55% | +$600.4K |
| CeriBell, Inc.(CBLL) | 435,239 | 386,786 | -48,453 | $9.54M | $7.09M | 0.47% | -$2.46M |
| LivaNova PLCSHS(LIVN) | 118,054 | 108,354 | -9,700 | $7.26M | $6.89M | 0.46% | -$376.9K |
| Establishment Labs Holdings Inc.(ESTA) | 112,664 | 103,464 | -9,200 | $8.21M | $5.87M | 0.39% | -$2.34M |
| Prime Medicine, Inc.(PRME) | 0 | 1,590,832 | +1,590,832 | $0 | $5.54M | 0.37% | +$5.54M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 448,110 | 415,710 | -32,400 | $3.67M | $5.27M | 0.35% | +$1.60M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 700,000 | +700,000 | $0 | $5.07M | 0.34% | +$5.07M |
| Ardelyx Inc | 0 | 733,350 | +733,350 | $0 | $4.39M | 0.29% | +$4.39M |
| Invivyd, Inc.(IVVD) | 2,681,159 | 2,648,659 | -32,500 | $6.62M | $3.44M | 0.23% | -$3.18M |
| Atara Biotherapeutics Inc | 441,701 | 441,701 | 0 | $7.99M | $2.09M | 0.14% | -$5.90M |
| AgomAb Therapeutics NVADS(AGMB) | 0 | 156,250 | +156,250 | $0 | $1.64M | 0.11% | +$1.64M |
| Pliant Therapeutics, Inc.(PLRX) | 1,616,228 | 772,126 | -844,102 | $1.97M | $972.9K | 0.06% | -$998.9K |
| Kalaris Therapeutics, Inc.(KLRS) | 82,955 | 0 | -82,955 | $700.1K | $0 | — | -$700.1K |
| Rapt Therapeutics Inc | 885,927 | 0 | -885,927 | $30.01M | $0 | — | -$30.01M |
| Repare Therapeutics Inc | 1,586,174 | 0 | -1,586,174 | $4.12M | $0 | — | -$4.12M |
| Replimune Group, Inc.(REPL) | 1,099,756 | 0 | -1,099,756 | $10.69M | $0 | — | -$10.69M |